ANTOINETTE FLORES: Open Payments
NPI 1669140299 · BUCKEYE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,639 in 108 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,281 · 2025 $2,639
Food & beverage: $2,639
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $478 |
| Vanda Pharmaceuticals Inc. | 11 | $436 |
| ABBVIE INC. | 29 | $422 |
| Janssen Pharmaceuticals, Inc | 5 | $242 |
| Lundbeck LLC | 10 | $223 |
| E.R. Squibb & Sons, L.L.C. | 6 | $215 |
| Axsome Therapeutics, Inc. | 7 | $161 |
| Collegium Pharmaceutical, Inc. | 5 | $141 |
| Teva Pharmaceuticals USA, Inc. | 8 | $138 |
| Biogen, Inc. | 2 | $43 |
Products named: CAPLYTA, FANAPT, VRAYLAR, REXULTI, INVEGA SUSTENNA, COBENFY, Auvelity, Jornay PM.
Industry payments across AZ — which companies pay providers there.
